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Do not attempt cardiopulmonary resuscitation (DNACPR)
decisions are made commonly in healthcare but can be a source
of ethical concern and legal challenge. They differ from other
healthcare decisions because they are made in anticipation of a
future event and concern withholding, rather than giving, a
treatment. DNACPR decisions were introduced to protect
patients from invasive treatments that had little or no chance of
success. However, inconsistencies in decision making,
communication, and documentation have led to
misunderstandings about what DNACPRmeans and to delivery
of poorer care to some patients. Here we discuss the problems
with current practice and outline newer approaches that place
the patient, and their family, at the centre of the discussions.
We focus on overall treatment plans and supporting clinicians
and patients to make shared decisions about emergency
treatments.
DNACPR decisions
CPR is an invasive medical treatment that was never intended
to be given to patients who are dying from an irreversible
condition.1DNACPRdecisions provide away of communicating
when patients should not receive CPR, either because they do
not want it or because it has little chance of success (box 1).
They are an important mechanism for protecting patients from
harm, but they have taken on practical, legal, and emotional
significance far beyond their intended remit.6
A comprehensive review in the NHS found shortcomings in
considering, discussing, and implementing DNACPR decisions,
as well as unintended consequences.7 The effects on patients
and clinicians can be divided into three broad domains: futile
or inappropriate CPR attempts, difficult and delayed discussion
around DNACPR decisions, and inappropriate withholding of
other treatments.
Firstly, we know that frailty8 and comorbidities9 are associated
with worsening outcomes after cardiac arrest, and receiving
attempted CPR when it has little prospect of success is one of
the major concerns expressed both by patients approaching the
end of their natural lives and by their relatives.7 This concern
is well founded, as such attempts continue to take place.10 The
ethics of widespread and indiscriminate use of CPR without
balancing benefit with harms has been challenged.11
Secondly, doctors are often hesitant to initiate conversations
about DNACPR owing to concerns about causing distress to
the patient or fear of complaints.2 7 Patients rarely initiate
conversations, even though research shows that they would like
to discuss CPR.12Changing the focus of discussion from specific
treatment options to acceptable health states and valued life
might be more acceptable to them.13 Some doctors don’t
understand the legal position of patients and families in making
DNACPR decisions. The legal requirement to involve patients
in DNACPR decisions varies across jurisdictions. In some
countries DNACPR is prohibited,2 in others patients must
consent to a DNACPR decision. Doctors in the UKmust consult
the patient or their family when writing a DNACPR notice
unless doing so would cause “physical or psychological harm.”14
Finally, doctors and nurses can sometimes conflate DNACPR
decisions with end-of-life care and mistakenly think that other
treatment should not be given. Scenario studies show that
presence of a DNACPR note makes doctors significantly less
likely to take blood cultures, put in a central line, or refer to an
intensive care unit.15 Nurses were significantly less likely to
perform a variety of monitoring tasks and interventions for
patients with a DNACPR decision than for those without.16 In
clinical practice, patients with heart failure and a DNACPR
decision were less likely to have their left ventricular function
assessed or to receive secondary prevention than matched
counterparts without such notices.17 A study of referrals to a
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Box 1: Clinical context of CPR and DNACPR
DNACPR decisions are considered in three situations:
when a patient with capacity refuses CPR or a patient without capacity has recorded their refusal of CPR in advance
when CPR is judged very unlikely to be effective because the patient is dying from an irreversible condition
when the potential burdens of CPR outweigh the potential benefits
DNACPR policies are in widespread use. They exist in many countries,2 and 80-90% of those who die in hospital have a DNACPR in
place3
a primary focus on acute care settings and a lack of consistency in policies between care settings is still widespread
One in five CPR attempts made in hospital result in survival.4 Average survival rate in the community is one in 1023
The decision not to attempt CPR should be distinct from decisions to initiate palliative care or to withhold other treatments
Many patients with DNACPR decisions are discharged from hospital5
Standardised DNACPR forms (fig 1⇓) are often used to provide immediate access to decisions in the event of a cardiorespiratory arrest
medical intensive care unit showed that a DNACPR notice was
the only factor significantly associated with a decision to refuse
a patient admission.18
Clinicians are presented with an ethical dilemma: if they do not
discuss CPR with a patient and record a decision, the patient
may receive CPR that doesn’t work or that results in a quality
of life that may not be acceptable to them; if they do, others
may misinterpret it and compromise the patient’s overall care.
Deciding what would achieve overall benefit for each person
is compounded by the uncertainty of predicting future events.
DNACPR practice as it currently stands raises considerable
ethical concerns. Shifting the focus from a specific decision
about CPR to making personalised plans on broader emergency
care and treatment will help to tackle some of these concerns.
Integration with advance care planning
DNACPR decisions have historically been separate from
advance care plans. Some primary care doctors have been
encouraged or incentivised to consider both for certain patient
populations.19 Synergy with advance care planning can be
achieved by putting CPR decisions in the context of overall
goals of care and combining them with discussions about what
treatments (or outcomes) a patient would or would not want.
This kind of holistic approach has been adopted in Canada (box
2) and in paediatrics (box 3).
Alternative approaches
Several alternative models to DNACPR have been developed
(boxes 2 and 4). On the POLST form, doctors are asked to record
whether to attempt CPR and to tick a box to clarify whether
patients would want comfort measures, limited treatment, or
full treatment and whether they would want artificially
administered nutrition. A systematic review of 23 research
studies found that POLST is used most frequently by elderly,
white patients approaching the end of their lives.21Conversations
about POLST are usually initiated by a non-physician facilitator
who prepares the form for review and sign off by a clinician.
The forms allow around 35 combinations of treatment
preferences to be recorded. Do not attempt resuscitation, comfort
measures, and withholding of antibiotics and artificial nutrition
are recorded by approximately one third of patients. Many
patients who made the decision to withhold CPR have said they
would like to receive full active treatment in one or more
sections of the form, emphasising the need to include
recommendations about other aspects of care along with
resuscitation guidance. The review found that POLST is
generally well received by clinicians; they have confidence that
it reliably records patient preferences and helps inform the
delivery of overall care and treatment. Concerns included
managing family disagreements, inadequate education for
providers, and the time taken to complete POLST. Although
POLST seems to be effective at guiding treatments that are
consistent with the documented “orders,” more research is
needed to examine the quality of decisions and to explore patient
and family members’ experiences.
The Universal Form of Treatment Options (UFTO) was
developed iteratively for hospitals through a modified Delphi
approach with doctors, nurses, and patients. It sets the overall
goals of care as “active treatment” or “optimal supportive care”
and is considered for all patients who are admitted to hospital
with an acute illness. Amixedmethods evaluation reported that
82% of patients had UFTOs, a quarter of whom recorded
decisions to withhold CPR.22 Frequency and severity of harms
experienced by patients were significantly reduced when the
recommendation not to attempt CPRwas recordedwithin overall
goals of care on an UFTO rather than on a standalone DNACPR.
Interviews with clinicians and observation of ward practice
showed that the UFTO helped provide clarity of goals of care
and reduced negative associations with resuscitation decisions
for clinicians. It changed the subject of conversations at nurse
handover from resuscitation decisions to the patient’s condition
and overall goals of care. This qualitative work provides a
suggested mechanism for the observed reduction in harms.
Towards a solution: development of
ReSPECT
Patients, clinicians, healthcare commissioners, and regulators
came together in a 100 strong meeting in 2014 to consider the
role of DNACPR decisions, following a review of published
evidence and evaluation of their use in the NHS.7 The group
agreed that patient and family involvement in decisions needed
improving and that resuscitation decisions should be considered
in the context of overall treatment plans.
After this meeting 37 stakeholders (including patient advocates)
convened regularly to develop an approach that could meet the
needs of different care settings and travel with the patient. They
used the approaches above as the starting point and drew upon
examples of best practice in the UK and internationally. They
agreed that, although a standardised framework is required, the
approach should focus on individual preferences and tailored
clinical guidance rather than standardised forms, encouraging
person centred planning and care.
The group agreed that the aims should be to contextualise
resuscitation decisions among overall goals of care; facilitate
early discussion with patients and their families; and restrict
documentation to a single sheet of paper (or digital equivalent),
for access in an emergency. A public consultation process
attracted over 1000 responses. The vast majority (91%) of
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Box 2: Alternative approaches in North America
The Physician Order for Life Sustaining Treatment (POLST; http://polst.org/about-the-national-polst-paradigm/what-is-polst/) was developed
in Oregon with the aim of ensuring that patient preferences for end-of-life care (including whether they wanted CPR) were honoured. It is
intended for those who are seriously ill or frail. POLST, or versions of it, are now established in more than 20 US states.
In Canada, an adapted version—Medical Orders for Scope of Treatment (MOST; https://www.interiorhealth.ca/YourCare/PalliativeCare/
ToughDecisions/Documents/MOST%20ACP%20cycle%20for%20patients.pdf)—is used to encourage people to “talk early, talk often.” The
MOST form has specific tick boxes for treatments such as blood products and dialysis. It is supported by excellent infographics showing
how advance care planning, MOST, and goals of care can be integrated.
Box 3: Babies, children, and young people
Advance care planning is well established in babies, children, and young people; in many areas it is delivered using standardised
documentation; eg, the Child and Young Persons Advance Care Plan (CYPACP: http://cypacp.nhs.uk), Deciding Right (http://www.
nescn.nhs.uk/common-themes/deciding-right/, or, in Scotland, Child and Young Persons Acute Deterioration Management CYPADM
(http://www.gov.scot/Topics/Health/Quality-Improvement-Performance/peolc/CYPADM)
A complex interplay exists between the decision making roles of the child and their parents, especially where older children are involved
Widespread practice includes a third resuscitation decision that specifies some, but not all, resuscitative measures as appropriate. This
is specifically captured in CYPACP paperwork
Legal status of 16 and 17 year olds varies considerably by country: it is important to be familiar with local legislation in this area
Courts are increasingly being used to resolve conflicting views regarding appropriate life sustaining therapies
Box 4: Alternative approaches in the UK
All of these approaches replace isolated resuscitation decisions with broader goals of care, encourage earlier conversations with patients,
and facilitate clear handover.
Universal Form of Treatment Options (UFTO)—UFTOwas developed in Cambridge University Hospitals from focus groups with clinicians
and patients and was informed by behavioural economics literature.20 UFTO is for all patients in a hospital setting, not just those
approaching the end of life. The form provides a dichotomous choice between goals of care (active treatment or optimal supportive
care), a box in which more specific or nuanced instructions can be written, and documentation of the CPR decision
Treatment Escalation Plans (TEPs)—TEPs were introduced as a replacement for the DNACPR process at Torbay Hospital, South
Devon, in 2006. Their use spread locally in 2012 to cover all health providers in the acute and community sectors across Devon (population
1.1 million). Many local care homes have embraced the concept; 30% of elderly inpatients now arrive at Torbay Hospital with a TEP.
Unwell and Potentially Deteriorating Patient Plan (UP)—UP was developed in oncology at Gloucestershire Hospitals NHS Trust and
has been further refined through a multidisciplinary working group including representatives from intensive care, palliative care, medicine,
and surgery. UP includes explicit guidance on escalation of treatment. Evaluation of and feedback on UP have been positive; rates of
CPR discontinued on grounds of the National Cardiac Arrest Audit criterion of “futility” have fallen from 17% in 2011 to 2% in 2016
Deciding Right—In the north east of England, Deciding Right puts CPR decisions into a wider context of planning emergency care in
advance and in the context of mental capacity legislation. A free app is available to aid decision making. See http://www.nescn.nhs.uk/
common-themes/deciding-right/
respondents agreed with the aims. Inclusion of the terms
“recommended” (to explain that the plan is not legally binding)
and “summary” (to emphasise that more detailed information
should be recorded in health records and in advance care plans)
led to the acronym: Recommended Summary Plan for
Emergency Care and Treatment (ReSPECT; www.
respectprocess.org.uk) (fig 2⇓).
ReSPECT was designed not only to replace DNACPR forms
but to provide additional support for conversations about goals
of care and to provide guidance to clinicians about which
treatments would or would not be wanted in an emergency in
the event of a patient not having capacity to make decisions for
themselves (box 5).
The ReSPECT process can be initiated in different care settings,
including admission to hospital, in the community or outpatient
clinic for patients with chronic or life limiting conditions, or at
admission to a care home. When these discussions are initiated
with people who are well there is a risk that they will
underestimate the state of ill health that they will tolerate and
how many interventions they might want.23 24 However there
may be benefits of thinking through possible future illnesses;
the earlier conversation may prepare the person for the acute
situation. Ideally the conversation should begin early with a
known clinician and should be revisited when there is a change
in situation—for example, admission to hospital. We have
provided guidance on discussing resuscitation and other
treatment decisions elsewhere, including more detail about the
ReSPECT process.25
ReSPECT tackles some of the barriers to having meaningful
conversations about resuscitation and other treatment decisions,
but logistical and ethical challenges remain. Community services
are under pressure, so finding time to have adequate
conversations may be difficult. Robust evaluation of the
effectiveness of ReSPECT in achieving its overall goals will
be essential.19
Time for a change?
Given the weight of evidence against DNACPR decisions being
made in isolation, how much (and what kind of) evidence is
needed before a new approach is adopted? Some of the
principles underpinning the new approaches to resuscitation
decisions are already widely accepted—clinicians need to
understand what is important to each individual patient and to
advise their patients which outcomes are clinically possible or
likely. Others are drawn from the research
literature—conversations should be undertaken proactively
before a crisis occurs; the option of attempting CPR should be
discussed with more people, not just those needing DNACPR
decisions or approaching the end of life; resuscitation decisions
should be contextualised within overall goals of care. The aim
of ensuring that recommendations are documented in such a
way that patients receive the right treatments at the right time
is one which is universally accepted. Changing the culture of
resuscitation decision making will not be easy, but newer
approaches may offer a step towards achieving this.
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Box 5: ReSPECT development
The group aimed to establish an approach which:
is developed with and is acceptable to patients, those important to them, healthcare professionals, carers, and other members of the
public
includes a decision support framework that supports patients and clinicians to have informed discussions about benefits and burdens
of emergency treatments including CPR
ensures that dialogue between the patient and clinicians is central to decision making
can be used across all care settings
can be used for people of all ages
is based on evidence and experience from other successful initiatives
contextualises a decision about CPR within overall goals of care, focusing on choices of treatments to be given rather than specifically
on withholding CPR
Records patient preferences and treatment decisions to guide clinicians in an emergency when the patient lacks capacity to make
decisions for themselves
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